# A study on the role of Tai Chi training in improving type 2 diabetes mellitus

**Authors:** Qiang Yang, Lincheng Li, Mingcai Sun, Hongcheng Luo, Chunyu Zhuang

PMC · DOI: 10.3389/fpubh.2026.1730335 · Frontiers in Public Health · 2026-02-06

## TL;DR

This study shows that Tai Chi training can improve type 2 diabetes by reducing inflammation, improving gut health, and enhancing body composition.

## Contribution

The study demonstrates Tai Chi's novel impact on gut microbiota and inflammation in type 2 diabetes patients.

## Key findings

- Tai Chi training significantly reduced body weight, BMI, and blood glucose levels in T2DM patients.
- Training increased gut microbiota diversity and decreased harmful bacteria while boosting anti-inflammatory markers.
- Intestinal barrier function improved, as indicated by reduced D-lactate and zonulin levels.

## Abstract

To explore the role of Tai Chi training in improving Type 2 Diabetes Mellitus (T2DM) based on gut microbiota, serum inflammatory factors, and intestinal mucosal barrier function.

Thirty-six patients with T2DM underwent 6 months of Tai Chi training. Body composition, biochemical indicators (fasting blood glucose, glycated hemoglobin, etc.), serum inflammatory factors (Tumor Necrosis Factor-α (TNF-α), Interleukin-6 (IL-6), etc.), and gut microbiota (16S rRNA sequencing) were measured.

After 6 months of Tai Chi training, significant reductions were observed in body weight, BMI, waist circumference, and body fat percentage (p < 0.05), while lean body mass increased significantly (p < 0.05). Fasting blood glucose, glycated hemoglobin, insulin resistance index (HOMA-IR), and total cholesterol levels decreased significantly (p < 0.01). C-reactive protein (CRP), TNF-α, IL-6, IL-1β, and IL-8 levels decreased significantly (p < 0.01), while the anti-inflammatory factor IL-10 increased significantly (p < 0.01). The Chao1 and Shannon indices increased significantly (p < 0.05). The abundance of beneficial bacteria increased significantly, while the abundance of harmful bacteria decreased significantly (p < 0.01). Markers of intestinal mucosal barrier function, including D-lactate and zonulin, decreased significantly (p < 0.01), while the level of milk fat globule-EGF factor 8 (MFG-E8) increased significantly (p < 0.01).

Tai Chi training can improve blood glucose homeostasis, gut microbiota richness and diversity, intestinal mucosal barrier function, and systemic inflammatory status in T2DM patients. Tai Chi training may be an important approach for personalized treatment of T2DM.

## Linked entities

- **Proteins:** IL6 (interleukin 6), IL1B (interleukin 1 beta), CXCL8 (C-X-C motif chemokine ligand 8), IL10 (interleukin 10), MFGE8 (milk fat globule EGF and factor V/VIII domain containing)
- **Diseases:** Type 2 Diabetes Mellitus (MONDO:0005148), T2DM (MONDO:0005148)

## Full-text entities

- **Genes:** HP (haptoglobin) [NCBI Gene 3240] {aka HP2ALPHA2, HPA1S}, IRS1 (insulin receptor substrate 1) [NCBI Gene 3667] {aka HIRS-1}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, CLEC7A (C-type lectin domain containing 7A) [NCBI Gene 64581] {aka BGR, CANDF4, CD369, CLECSF12, DECTIN1, SCARE2}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, HK1 (hexokinase 1) [NCBI Gene 3098] {aka CNSHA5, HK, HK1-ta, HK1-tb, HK1-tc, HKD}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, CLEC4D (C-type lectin domain family 4 member D) [NCBI Gene 338339] {aka CD368, CLEC-6, CLEC6, CLECSF8, Dectin-3, MCL}, PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) [NCBI Gene 5562] {aka AMPK, AMPK alpha 1, AMPKa1}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, MFGE8 (milk fat globule EGF and factor V/VIII domain containing) [NCBI Gene 4240] {aka BA46, EDIL1, HMFG, HsT19888, MFG-E8, MFGM}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** metabolic disease (MESH:D008659), retinopathy (MESH:D058437), Obesity (MESH:D009765), substance abuse (MESH:D019966), diabetes (MESH:D003920), chronic inflammation (MESH:D007249), HL (MESH:C538324), hyperglycemia (MESH:D006943), neuropathy (MESH:D009422), fungal (MESH:D009181), T2DM (MESH:D003924), inflammatory bowel diseases (MESH:D015212), nephropathy (MESH:D007674), weight loss (MESH:D015431), Insulin Resistance (MESH:D007333), cardiovascular disease (MESH:D002318), hypoglycemia (MESH:D007003), Endocrine disorders (MESH:D004700), ischemic heart disease (MESH:D017202), malabsorption syndromes (MESH:D008286)
- **Chemicals:** cholesterol (MESH:D002784), amoxicillin (MESH:D000658), blood glucose (MESH:D001786), TG (MESH:D014280), glycolate (MESH:C031149), glucose (MESH:D005947), SCFAs (MESH:D005232), tryptophan (MESH:D014364), alcohol (MESH:D000438), lipid (MESH:D008055), agarose (MESH:D012685), roxithromycin (MESH:D015575), cephalosporins (MESH:D002511), butyrate (MESH:D002087), penicillin (MESH:D010406), D-LA (-), bile acid (MESH:D001647)
- **Species:** Ruminococcus (genus) [taxon 1263], Fungi (kingdom) [taxon 4751], Enterococcus (genus) [taxon 1350], Veillonella (genus) [taxon 29465], Lactobacillus (genus) [taxon 1578], Escherichia coli (E. coli, species) [taxon 562], Candida albicans (species) [taxon 5476], Oryza sativa (Asian cultivated rice, species) [taxon 4530], Bacillota (clostridial firmicutes, phylum) [taxon 1239], Enterobacteriaceae (enterobacteria, family) [taxon 543], Clostridium (genus) [taxon 1485], Homo sapiens (human, species) [taxon 9606], Faecalibacterium prausnitzii (species) [taxon 853], Bifidobacterium (genus) [taxon 1678], Fusobacterium (genus) [taxon 848], Bacteroides (genus) [taxon 816]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12920532/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12920532/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC12920532/full.md

---
Source: https://tomesphere.com/paper/PMC12920532